JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
This Quarter Return
+2.96%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$6.14B
AUM Growth
+$6.14B
(+21%)
Cap. Flow
+$750M
Cap. Flow
% of AUM
12.22%
Top 10 Holdings %
Top 10 Hldgs %
34.26%
Holding
1,512
New
358
Increased
286
Reduced
276
Closed
320
Top Buys
| 1 |
Apple
AAPL
|
$367M |
| 2 |
NVIDIA
NVDA
|
$173M |
| 3 |
NXP Semiconductors
NXPI
|
$127M |
| 4 |
Amgen
AMGN
|
$104M |
| 5 |
argenx
ARGX
|
$86.7M |
Top Sells
| 1 |
Golar LNG
GLNG
|
$154M |
| 2 |
Visa
V
|
$52.3M |
| 3 |
Cedar Fair
FUN
|
$51.8M |
| 4 |
Geron
GERN
|
$46.9M |
| 5 |
ResMed
RMD
|
$36M |
Sector Composition
| 1 | Healthcare | 22.29% |
| 2 | Technology | 17.84% |
| 3 | Industrials | 7% |
| 4 | Energy | 6.23% |
| 5 | Financials | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Advanced Micro Devices
AMD
$263B
| $19M | 0.14% |
115,890
+37,134
| +47% | +$6.09M |
|
52
UnitedHealth
UNH
$279B
| $18.5M | 0.13% |
31,670
-20,072
| -39% | -$11.7M |
|
|
HES
53
DELISTED
Hess
HES
| $17.7M | 0.13% |
130,279
+56,642
| +77% | +$7.69M |
|
54
Gilead Sciences
GILD
$140B
| $16.9M | 0.12% |
201,276
-119,519
| -37% | -$10M |
|
55
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.7B
| $16.9M | 0.12% |
+500,000
| New | +$16.9M |
|
56
Merck
MRK
$210B
| $16.6M | 0.12% |
145,855
+36,835
| +34% | +$4.18M |
|
57
Tandem Diabetes Care
TNDM
$834M
| $16M | 0.11% |
378,336
+293,580
| +346% | +$12.5M |
|
58
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.4B
| $15.8M | 0.11% |
140,028
-185,986
| -57% | -$21M |
|
59
Waters Corp
WAT
$17.3B
| $15.3M | 0.11% |
42,520
+34,580
| +436% | +$12.4M |
|
60
Vertex Pharmaceuticals
VRTX
$102B
| $15.2M | 0.11% |
32,643
-27,632
| -46% | -$12.9M |
|
61
Pfizer
PFE
$141B
| $15M | 0.11% |
517,531
-694,330
| -57% | -$20.1M |
|
62
iShares MSCI USA Quality Factor ETF
QUAL
$54.1B
| $14.5M | 0.1% |
80,955
+4,751
| +6% | +$852K |
|
63
Bristol-Myers Squibb
BMY
$96.7B
| $14.4M | 0.1% |
278,622
+47,568
| +21% | +$2.46M |
|
64
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.86B
| $14.3M | 0.1% |
+108,541
| New | +$14.3M |
|
65
Invesco S&P 500 Quality ETF
SPHQ
$15.1B
| $14.3M | 0.1% |
212,066
+13,374
| +7% | +$900K |
|
66
Jones Lang LaSalle
JLL
$14.2B
| $14.2M | 0.1% |
+52,639
| New | +$14.2M |
|
67
Tarsus Pharmaceuticals
TARS
$2.44B
| $13.8M | 0.1% |
420,758
| – | – |
|
68
DraftKings
DKNG
$23.7B
| $13.8M | 0.1% |
352,203
-409,996
| -54% | -$16.1M |
|
69
Elevance Health
ELV
$72.4B
| $13.4M | 0.1% |
25,839
+7,416
| +40% | +$3.86M |
|
70
Lithia Motors
LAD
$8.51B
| $13.4M | 0.1% |
+42,198
| New | +$13.4M |
|
71
Spyre Therapeutics
SYRE
$1.02B
| $13.4M | 0.1% |
454,807
+357,234
| +366% | +$10.5M |
|
72
Schlumberger
SLB
$52.2B
| $13.3M | 0.1% |
317,095
+267,095
| +534% | +$11.2M |
|
73
Verizon
VZ
$184B
| $13.1M | 0.09% |
291,664
+151,994
| +109% | +$6.83M |
|
74
Alnylam Pharmaceuticals
ALNY
$58.6B
| $13M | 0.09% |
47,193
+44,893
| +1,952% | +$12.3M |
|
75
Lumentum
LITE
$9.37B
| $12.7M | 0.09% |
201,013
+185,013
| +1,156% | +$11.7M |
|